Expert: Pfizer Requests the Approval of COVID-19 Vaccine for Ages 5 to 11
Anna Legreid-Dopp, PharmD, Senior Director of Clinical Guidelines and Quality Improvement at the American Society of Health-System Pharmacists discusses Pfizer’s request to approve their COVID-19 vaccine for children 5 to 11.
For a Contemporary Clinic interview, Anna Legreid-Dopp, PharmD, Senior Director of Clinical Guidelines and Quality Improvement at the American Society of Health-System Pharmacists discussed Pfizer’s request to approve their COVID-19 vaccine for children 5 to 11.
She talked about what parents should know, the benefits of the vaccine for children this young, and why the FDA proceeds with extreme caution when considering the approval for the 5 to 11 age group.
Treating Anxiety in Children and Teens Who Present Comorbidities
June 8th 2020Susan Van Cleve, Clinical Professor and Primary Care Pediatric Nurse Practitioner Program Director, University of Iowa College of Nursing, discusses how to identify and treat anxiety in children and teens who present comorbidities.
